An open-label study of the effect of intravenous epothilone D [KOS 862] on treatment response in patients with metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Sep 2010
At a glance
- Drugs Epothilone D (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Actual initiation date (Nov 2003) added as reported by Roche record.
- 19 Aug 2007 Status changed from in progress to completed.
- 20 Jun 2006 New trial record.